Consun Pharmaceutical Group Limited (1681.HK)
HKD 9.74
(0.62%)
HKD 9.74
(0.62%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 511.53 Million CNY | 11.16% |
| 2022 | 460.17 Million CNY | -24.68% |
| 2021 | 610.97 Million CNY | 11.2% |
| 2020 | 549.41 Million CNY | -0.75% |
| 2019 | 553.56 Million CNY | 41.02% |
| 2018 | 392.53 Million CNY | -30.9% |
| 2017 | 568.1 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 507.69 Million CNY | 0.0% |
| 2023 Q2 | 537.69 Million CNY | 0.0% |
| 2023 Q4 | 511.53 Million CNY | 0.0% |
| 2023 FY | 511.53 Million CNY | 11.16% |
| 2022 FY | 460.17 Million CNY | -24.68% |
| 2022 Q4 | 460.17 Million CNY | 0.0% |
| 2022 Q2 | 478.37 Million CNY | 0.0% |
| 2021 Q4 | 610.97 Million CNY | 0.0% |
| 2021 FY | 610.97 Million CNY | 11.2% |
| 2021 Q2 | 592.15 Million CNY | 0.0% |
| 2020 Q4 | 549.41 Million CNY | 0.0% |
| 2020 Q2 | 585.15 Million CNY | 0.0% |
| 2020 FY | 549.41 Million CNY | -0.75% |
| 2019 FY | 553.56 Million CNY | 41.02% |
| 2019 Q2 | 714.16 Million CNY | 0.0% |
| 2019 Q4 | 553.56 Million CNY | 0.0% |
| 2018 Q4 | 392.53 Million CNY | 0.0% |
| 2018 FY | 392.53 Million CNY | -30.9% |
| 2018 Q2 | 448.52 Million CNY | 0.0% |
| 2017 FY | 568.1 Million CNY | 0.0% |
| 2017 Q2 | 566.03 Million CNY | 0.0% |
| 2017 Q4 | 568.1 Million CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 Q2 | 20 Million CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q2 | 37 Million CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -7411.514% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | 84.974% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -324.827% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | -10.974% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -104937.782% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -150.58% |
| Essex Bio-Technology Limited | 294.02 Million HKD | -73.978% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | -53.235% |
| PuraPharm Corporation Limited | 424.77 Million HKD | -20.426% |
| SSY Group Limited | 3.37 Billion HKD | 84.839% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -283.439% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | 31.739% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 99.404% |